- Vaccines
- Antivirals
- Antibiotics
- Parasiticides
- Anti-inflammatory drugs
- Others
Livestock Pharmaceuticals Market size was valued at USD 18.2 billion in 2022 and is expected to reach a value of USD 30.79 billion by 2028, at a significant CAGR of 7.8% from 2023-29. Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed. Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofis Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.
Livestock Pharmaceuticals Market Key Developments:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the growth of the market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of the market.
The Livestock pharmaceuticals market size was valued at USD 18.2 billion in 2022.
The key segments covered in the livestock pharmaceuticals market are technology, components, application, and end-users.
The Livestock pharmaceuticals market key players are Zoetis Inc. (U.S), Virbac S.A. (France), Vactoquinol S.A. (France), Merck & Co., Inc. (U.S), Bayer AG (Germnay), Boehringer Ingelheim GmbH (Germany), Ceva Santac Animale (France), Eli Lilly and Company (U.S), Hester biosciences (India)
1. Executive Summary |
2. Global Livestock Pharmaceuticals Market Introduction |
2.1. Global Livestock Pharmaceuticals Market Taxonomy |
2.2. Global Livestock Pharmaceuticals Market Definitions |
2.2.1. Product |
2.2.2. Animal |
2.2.3. Distribution Channel |
3. Global Livestock Pharmaceuticals Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Livestock Pharmaceuticals Market Dynamic Factors - Impact Analysis |
3.6. Global Livestock Pharmaceuticals Market Competition Landscape |
4. Global Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Livestock Pharmaceuticals Market, By Product, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1. Anti-infectives/ Antibiotics |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Parasiticides |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Reproduction Management |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Vaccines |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. High-density Polyethylene (HDPE) |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Livestock Pharmaceuticals Market Forecast, By Animal, 2018-2022 and Forecast, 2023-2029 |
6.1. Cattle |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Sheep |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Goats |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Swine |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Horses |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Others |
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7. Global Livestock Pharmaceuticals Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Region, 2023-2029 |
8. North America Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Anti-infectives/ Antibiotics |
8.1.2. Parasiticides |
8.1.3. Reproduction Management |
8.1.4. Vaccines |
8.1.5. Others |
8.2. Animal Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Cattle |
8.2.2. Sheep |
8.2.3. Goats |
8.2.4. Swine |
8.2.5. Horses |
8.2.6. Others |
8.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.3.1. Veterinary Hospitals |
8.3.2. veterinary Pharmacies |
8.3.3. Others |
8.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
8.5. North America Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2023-2029 |
8.6. North America Livestock Pharmaceuticals Market Dynamics Trends |
9. Europe Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Anti-infectives/ Antibiotics |
9.1.2. Parasiticides |
9.1.3. Reproduction Management |
9.1.4. Vaccines |
9.1.5. Others |
9.2. Animal Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Cattle |
9.2.2. Sheep |
9.2.3. Goats |
9.2.4. Swine |
9.2.5. Horses |
9.2.6. Others |
9.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Veterinary Hospitals |
9.3.2. veterinary Pharmacies |
9.3.3. Others |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. Germany |
9.4.2. UK |
9.4.3. France |
9.4.4. Spain |
9.4.5. Italy |
9.4.6. Russia |
9.4.7. Poland |
9.4.8. Rest of Europe |
9.5. Europe Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Raw Material Type, End -Use and Country, 2023-2029 |
9.6. Europe Livestock Pharmaceuticals Market Dynamics Trends |
10. Asia-Pacific Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Anti-infectives/ Antibiotics |
10.1.2. Parasiticides |
10.1.3. Reproduction Management |
10.1.4. Vaccines |
10.1.5. Others |
10.2. Animal Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Cattle |
10.2.2. Sheep |
10.2.3. Goats |
10.2.4. Swine |
10.2.5. Horses |
10.2.6. Others |
10.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Veterinary Hospitals |
10.3.2. veterinary Pharmacies |
10.3.3. Others |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Japan |
10.4.2. China |
10.4.3. India |
10.4.4. ASEAN |
10.4.5. Australia & New Zealand |
10.4.6. Rest of Asia-Pacific |
10.5. Asia-Pacific Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2023-2029 |
10.6. Asia-Pacific Livestock Pharmaceuticals Market Dynamics Trends |
11. Latin America Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Anti-infectives/ Antibiotics |
11.1.2. Parasiticides |
11.1.3. Reproduction Management |
11.1.4. Vaccines |
11.1.5. Others |
11.2. Animal Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Cattle |
11.2.2. Sheep |
11.2.3. Goats |
11.2.4. Swine |
11.2.5. Horses |
11.2.6. Others |
11.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Veterinary Hospitals |
11.3.2. veterinary Pharmacies |
11.3.3. Others |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
11.5. Latin America Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2023-2029 |
11.6. Latin America Livestock Pharmaceuticals Market Dynamics Trends |
12. Middle East and Africa Livestock Pharmaceuticals Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Anti-infectives/ Antibiotics |
12.1.2. Parasiticides |
12.1.3. Reproduction Management |
12.1.4. Vaccines |
12.1.5. Others |
12.2. Animal Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Cattle |
12.2.2. Sheep |
12.2.3. Goats |
12.2.4. Swine |
12.2.5. Horses |
12.2.6. Others |
12.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Veterinary Hospitals |
12.3.2. veterinary Pharmacies |
12.3.3. Others |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Gulf Cooperation Council (GCC) Countries |
12.4.2. Israel |
12.4.3. South Africa |
12.4.4. Rest of MEA |
12.5. MEA Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2023-2029 |
12.6. MEA Livestock Pharmaceuticals Market Dynamics Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Zoetis Inc. (U.S) |
13.2.2. Virbac S.A. (France) |
13.2.3. Vétoquinol S.A. (France) |
13.2.4. Merck & Co., Inc. (U.S) |
13.2.5. Bayer AG (Germnay) |
13.2.6. Boehringer Ingelheim GmbH (Germany) |
13.2.7. Ceva Santé Animale (France) |
13.2.8. Eli Lilly and Company (U.S) |
13.2.9. Hester biosciences (India) |
14. Research Methodology |
15. Key Assumptions and Acronyms |